Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Forst

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
International Journal of Molecular Medicine|October 27, 1999
Germline mutations in the MEN1 gene: creation of a new splice acceptor site and insertion of 7 intron nucleotides into the mRNAM Engelbach, T Forst, T Hankeln, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]S Eckert, E Erdmann, R Lundershausen, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2009
[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]G Schernthaner, T Forst, D Gulba, et al.
Clinical Science (London, England : 1979)|March 24, 2000
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type IT Forst, D D De La Tour, T Kunt, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
International Journal of Molecular Medicine|October 27, 1999
Germline mutations in the MEN1 gene: creation of a new splice acceptor site and insertion of 7 intron nucleotides into the mRNAM Engelbach, T Forst, T Hankeln, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|May 1, 1997
Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudicationA Creutzig, M Bullinger, M Cachovan, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]S Eckert, E Erdmann, R Lundershausen, et al.
Diabetes, Obesity & Metabolism|April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)Z Skrivanek, B L Gaydos, J Y Chien, et al.
Deutsche Medizinische Wochenschrift (1946)|April 23, 2009
[Challenge in diabetes therapy: effects of glitazones beyond blood glucose control]G Schernthaner, T Forst, D Gulba, et al.
Clinical Science (London, England : 1979)|March 24, 2000
Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type IT Forst, D D De La Tour, T Kunt, et al.
Pageof 10